医学
阿达木单抗
相伴的
英夫利昔单抗
耐火材料(行星科学)
内科学
危险系数
胃肠病学
克罗恩病
置信区间
肿瘤坏死因子α
外科
疾病
物理
天体生物学
作者
Naoko Sugita,Kenji Watanabe,Noriko Kamata,Tomomi Yukawa,Koji Otani,Shuhei Hosomi,Yasuaki Nagami,Fumio Tanaka,Koichi Taira,Hirokazu Yamagami,Tetsuya Tanigawa,Masatsugu Shiba,Toshio Watanabe,Kazunari Tominaga,Daijiro Kabata,Ayumi Shintani,Tetsuo Arakawa,Yasuhiro Fujiwara
摘要
Concomitant ED therapy reduced ADA-LOR in IFX-intolerant or refractory patients in a dose-related manner. Reductions in the TNF-α levels by concomitant ED intake may contribute to reduce ADA-LOR in CD patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI